FlexifyMe Secures $2.4 Million to Revolutionize Pain Management
Investorsync desk1 min read
Deal sheet
$2.4 Million
- Stage
- Pre-Series A
- Sector
- HealthTech
- Announced
- 4 September 2025
FlexifyMe has raised $2.4 million in pre-Series A funding led by IvyCap Ventures, with participation from Signal Ventures and existing investors.
Founded by Manjeet Singh and Amit Bhayani in 2021, Pune, India, FlexifyMe is building an innovative chronic pain management platform that uses AI-powered posture and motion analysis with expert physiotherapy to find the root causes of chronic musculoskeletal pain.
It focuses on data-driven, trackable care to reduce unnecessary procedures and improve long-term patient outcomes.
It serves thousands of users in India and abroad and partners with enterprises, insurers, and healthcare networks.
The fresh capital will be used to expand its hybrid care online and offline, launch advanced posture and gait labs, and strengthen clinical research partnerships.
Thousands of users in India and abroad trust it.
Partners with enterprises, insurers, and healthcare networks for clinically validated results.
Source: company announcement. First posted on the Investorsync LinkedIn page.
From InvestorDB